FDA grants accelerated approval to dostarlimab for rectal cancer
The agency cleared Jemperli for a new use in locally advanced rectal cancer, saying it may let some patients skip chemotherapy, radiation, and surgery.
FDA, FDA press release, Drugs@FDA, SEC filing (5)